ATC codes:
N07AA01
EMLc
Indication
Myasthenia gravis
ICD11 code:
8C70.Z
INN
Neostigmine bromide
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > unspecified:
0.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate) ;
2.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate)
Oral > Solid > tablet: 15 mg (neostigmine bromide) (EML)
Oral > Solid > tablet: 15 mg (neostigmine bromide) (EML)
EML status history
First added in 2025
(TRS
1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Listings for medicines for treatment of myasthenia gravis are duplicated in this section from section 20.